查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1824241

生物资讯市场 - 预测 2025-2030

Bioinformatics Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 156 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

生物资讯市场规模：

生物资讯市场预计将从 2025 年的 151.34 亿美元成长到 2030 年的 303.61 亿美元，复合年增长率为 14.94%。

生物资讯学代表了计算科学与生物学研究的融合，它运用先进的分析工具来处理和解读复杂的生物资料集。这个跨学科领域涵盖基因和蛋白质功能的计算分析、演化关係的绘製以及蛋白质结构的预测，并已成为现代生物学研究和医学应用的重要组成部分。

市场动态和产业背景

随着先进的序列测定和蛋白质分析技术产生的数据呈指数级增长，调查方法已成为生物学研究的关键推动力。这个领域的重要性源自于对海量生物资料集进行管理、解读并从中获取有意义见解的根本需求，而这些资料集的规模之大，已经超出了传统分析能力的范畴。

现代生物学研究产生了前所未有的海量基因组学、蛋白质组学和代谢组学数据，这些数据需要先进的计算基础设施和专门的分析演算法。如此复杂的数据需要先进的研究解决方案，这些解决方案不仅要能够处理多维资料集，还要为医学应用和持续的研究进展提供准确且可操作的洞察。

市场的扩张反映出人们日益认识到计算生物学在加速科学发现、药物开发和个人化医疗方面的作用。随着生物研究的数据密集度日益提高，生物资讯学平台已成为从基础研究到临床应用的重要基础设施。

成长要素和投资趋势

公共和私营部门投资

政府机构和私人企业大力投资，透过运算解决方案提升生物研究能力，生物资讯市场因此受益匪浅。这些投资体现了他们对生物资讯学潜力的策略性认识，即透过先进的数据分析和新技术提供高品质的研究成果。

这种投资模式体现了其致力于建构全面的生物资讯学生态系统的决心，该生态系统旨在支持从基础生物学研究到应用医学研究的各类研究应用。此类资金支持有助于开发复杂的生物数据分析所需的先进分析平台、资料库基础设施和计算资源。

公共部门对生物资讯学的资助尤其凸显了该领域对国家研究重点、公共卫生计画和科学竞争力的重要性。私部门的投资透过刺激商业性生物资讯解决方案和专业分析服务的创新，补充了政府资金。

市场限制和实施挑战

技术成本障碍

生物资讯产业面临与先进分析设备和复杂软体平台高成本相关的重大挑战。次世代定序技术及其相关的运算基础设施需要大量的资金投入，这可能会限制小型机构的市场准入。

对于基因组学设备而言，成本是一个特别重要的考虑因素，先进的系统价格昂贵，以反映其先进的功能和分析能力。对于预算有限的小型製药公司和研究机构来说，购买多台基因组分析仪器的资金需求可能是一个重大障碍。

这些成本限制会造成市场分割，只有资金充足的研究机构才能充分利用尖端能力，从而限制广泛的市场扩张和整个研究界的创新传播。

技术复杂性和可用性挑战

生物资讯市场在软体可用性和技术可近性方面持续面临挑战。许多生物资讯学应用需要丰富的计算专业知识，这给缺乏专业程式设计技能但需要分析能力的实验研究人员带来了障碍。

复杂的分析能力与使用者友善介面之间的脱节限制了生物资讯学工具在科学研究领域的广泛应用。由于大多数实验研究人员缺乏正规的生物资讯学培训，因此直观易用的软体设计对于市场拓展至关重要。

目前的生物资讯学平台通常缺乏足够的使用者介面来弥补计算复杂性与实际研究应用之间的差距。这种可用性方面的差距限制了那些能够从生物资讯学功能中获益但缺乏操作复杂软体环境技术专业知识的研究人员的采用，从而限制了市场的成长。

战略市场展望

生物资讯市场处于一个动态的环境中，其特征是资料复杂性不断增加，但成本和可近性的挑战却不断增加。在先进的分析能力和使用者友善的介面之间取得平衡，同时解决限制不同研究机构进入市场的成本障碍，是成功的关键。

本报告的主要优点

  • 深入分析：深入了解主要和新兴地区的市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场。
  • 竞争格局：了解主要企业所采用的策略策略，并了解采用正确的策略的市场渗透潜力。
  • 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力进行策略决策，并在动态环境中开闢新的业务流和收益。
  • 适合广泛的使用者：对于新兴企业、研究机构、顾问、中小企业和大型企业来说都是有益且具有成本效益的。

它有什么用途？

产业与市场考量、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

调查范围

  • 2022 年至 2024 年的历史数据和 2025 年至 2030 年的预测数据
  • 成长机会、挑战、供应链前景、法律规范与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 收益成长和预测细分市场和区域分析（包括国家）
  • 公司概况（尤其是财务状况和关键发展）。

目录

第一章执行摘要

第二章市场概述

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 经营状况

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策法规
  • 策略建议

第四章 技术展望

第五章生物资讯市场（按应用）

  • 介绍
  • 药物研发
  • 个人化预防医学
  • 基因组学和遗传学研究
  • 分子医学
  • 临床诊断
  • 法医学和环境生物资讯学
  • 其他的

第六章 生物资讯市场（依生物资料类型）

  • 介绍
  • 基因组学
  • 转录组学
  • 蛋白质体学
  • 代谢体学
  • 药物基因组学
  • 化学资讯学
  • 表观基因
  • 其他的

第七章 生物资讯市场（依最终使用者）

  • 介绍
  • 製药和生物技术公司
  • 学术研究机构
  • 农业研究所
  • 医院和诊所
  • 合约研究组织（CRO）
  • 其他的

第八章生物资讯市场（按地区）

  • 介绍
  • 北美洲
    • 按用途
    • 依生物资料类型
    • 按最终用户
    • 按国家
      • 美国
      • 加拿大
      • 墨西哥
  • 南美洲
    • 按用途
    • 依生物资料类型
    • 按最终用户
    • 按国家
      • 巴西
      • 阿根廷
      • 其他的
  • 欧洲
    • 按用途
    • 依生物资料类型
    • 按最终用户
    • 按国家
      • 英国
      • 德国
      • 法国
      • 西班牙
      • 其他的
  • 中东和非洲
    • 按用途
    • 依生物资料类型
    • 按最终用户
    • 按国家
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 其他的
  • 亚太地区
    • 按用途
    • 依生物资料类型
    • 按最终用户
    • 按国家
      • 中国
      • 日本
      • 印度
      • 韩国
      • 台湾
      • 其他的

第九章竞争格局及分析

  • 主要企业和策略分析
  • 市占率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十章：公司简介

  • Thermo Fisher Scientific Inc.
  • Illumina Inc.
  • QIAGEN NV
  • Agilent Technologies Inc.
  • PerkinElmer Inc.
  • Eurofins Scientific
  • DNAnexus Inc.
  • BGI Group
  • Waters Corporation
  • DNASTAR Inc.

第十一章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 调查方法
  • 简称

图表目录

表格列表

简介目录
Product Code: KSI061610545

Bioinformatics Market Size:

The Bioinformatics Market is expected to grow from USD 15.134 billion in 2025 to USD 30.361 billion in 2030, at a CAGR of 14.94%.

Bioinformatics represents the convergence of computational science and biological research, employing sophisticated analytical tools to process and interpret complex biological datasets. This interdisciplinary field encompasses the computational analysis of gene and protein functions, evolutionary relationship mapping, and three-dimensional protein structure prediction, establishing itself as an indispensable component of modern biological research and medical applications.

Market Dynamics and Industry Context

The bioinformatics sector has emerged as a critical enabler of biological research, driven by the exponential growth of data generated through advanced sequencing technologies and protein analysis methodologies. The field's importance stems from the fundamental need to manage, interpret, and derive meaningful insights from massive biological datasets that exceed traditional analytical capabilities.

Modern biological research generates unprecedented volumes of genomic, proteomic, and metabolomic data requiring sophisticated computational infrastructure and specialized analytical algorithms. This data complexity necessitates advanced bioinformatics solutions capable of handling multi-dimensional datasets while providing accurate, actionable insights for medical applications and continued research advancement.

The market's expansion reflects increasing recognition of computational biology's role in accelerating scientific discovery, drug development, and personalized medicine initiatives. As biological research becomes increasingly data-intensive, bioinformatics platforms serve as essential infrastructure supporting everything from basic research to clinical applications.

Growth Drivers and Investment Trends

Public and Private Sector Investment

The bioinformatics market benefits significantly from substantial investments by government agencies and private sector organizations seeking to advance biological research capabilities through computational solutions. These investments reflect strategic recognition of bioinformatics' potential to enable high-quality research outcomes through advanced data analysis and emerging technologies.

Investment patterns demonstrate commitment to developing comprehensive bioinformatics ecosystems that support diverse research applications, from fundamental biological investigations to applied medical research. This financial backing enables development of sophisticated analytical platforms, database infrastructure, and computational resources necessary for complex biological data analysis.

The public sector's involvement in bioinformatics funding particularly emphasizes the field's importance for national research priorities, public health initiatives, and scientific competitiveness. Private sector investments complement government funding by driving innovation in commercial bioinformatics solutions and specialized analytical services.

Market Constraints and Implementation Challenges

Technology Cost Barriers

The bioinformatics industry faces significant challenges related to the high costs associated with advanced analytical equipment and sophisticated software platforms. Next-generation sequencing technologies and associated computational infrastructure require substantial financial investments that can limit market accessibility for smaller organizations.

Genomics instrumentation represents a particularly significant cost consideration, with advanced systems requiring premium pricing that reflects their sophisticated features and analytical capabilities. The financial requirements for acquiring multiple genomic instruments create substantial barriers for smaller pharmaceutical companies and research institutions operating with limited budgets.

These cost constraints create market segmentation where only well-funded organizations can fully leverage cutting-edge bioinformatics capabilities, potentially limiting broader market expansion and innovation diffusion throughout the research community.

Technical Complexity and Usability Challenges

The bioinformatics market confronts ongoing challenges related to software usability and technical accessibility. Many bioinformatics applications require extensive computational expertise, creating barriers for experimental researchers who lack specialized programming skills but need access to analytical capabilities.

The disconnect between sophisticated analytical capabilities and user-friendly interfaces limits broader adoption of bioinformatics tools within the research community. Most experimental researchers operate without formal bioinformatics training, making intuitive, accessible software design crucial for market expansion.

Current bioinformatics platforms often lack appropriate user interfaces that bridge the gap between computational complexity and practical research applications. This usability gap constrains market growth by limiting adoption among researchers who could benefit from bioinformatics capabilities but lack technical expertise to navigate complex software environments.

Strategic Market Outlook

The bioinformatics market operates within a dynamic environment characterized by increasing data complexity offset by cost and accessibility challenges. Success requires balancing advanced analytical capabilities with user-friendly interfaces while addressing cost barriers that limit market participation across diverse research organizations.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Bioinformatics Market Segmentation:

By Application

  • Drug Discovery and Development
  • Personalized and Preventive Medicine
  • Genomics and Genetic Research
  • Molecular Medicine
  • Clinical Diagnostics
  • Forensic and Environmental Bioinformatics
  • Others

By Biological Data Type

  • Genomics
  • Transcriptomics
  • Proteomics
  • Metabolomics
  • Pharmacogenomics
  • Cheminformatics
  • Epigenomics
  • Others

By End-User

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Agricultural Research Organizations
  • Hospitals and Clinics
  • Contract Research Organizations (CROs)
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. BIOINFORMATICS MARKET BY APPLICATION

  • 5.1. Introduction
  • 5.2. Drug Discovery and Development
  • 5.3. Personalized and Preventive Medicine
  • 5.4. Genomics and Genetic Research
  • 5.5. Molecular Medicine
  • 5.6. Clinical Diagnostics
  • 5.7. Forensic and Environmental Bioinformatics
  • 5.8. Others

6. BIOINFORMATICS MARKET BY BIOLOGICAL DATA TYPE

  • 6.1. Introduction
  • 6.2. Genomics
  • 6.3. Transcriptomics
  • 6.4. Proteomics
  • 6.5. Metabolomics
  • 6.6. Pharmacogenomics
  • 6.7. Cheminformatics
  • 6.8. Epigenomics
  • 6.9. Others

7. BIOINFORMATICS MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Pharmaceutical and Biotechnology Companies
  • 7.3. Academic and Research Institutes
  • 7.4. Agricultural Research Organizations
  • 7.5. Hospitals and Clinics
  • 7.6. Contract Research Organizations (CROs)
  • 7.7. Others

8. BIOINFORMATICS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Application
    • 8.2.2. By Biological Data Type
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Application
    • 8.3.2. By Biological Data Type
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Application
    • 8.4.2. By Biological Data Type
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Application
    • 8.5.2. By Biological Data Type
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Application
    • 8.6.2. By Biological Data Type
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Taiwan
      • 8.6.4.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Thermo Fisher Scientific Inc.
  • 10.2. Illumina Inc.
  • 10.3. QIAGEN N.V.
  • 10.4. Agilent Technologies Inc.
  • 10.5. PerkinElmer Inc.
  • 10.6. Eurofins Scientific
  • 10.7. DNAnexus Inc.
  • 10.8. BGI Group
  • 10.9. Waters Corporation
  • 10.10. DNASTAR Inc.

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations

LIST OF FIGURES

LIST OF TABLES